Miragen Therapeutics Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Miragen Therapeutics Inc (miRagen), formerly Signal Genetics Inc is a clinical stage biopharmaceutical company. The company discovers and develops novel RNA-based therapeutics, with a core focus on microRNAs and their roles in diseases. It focuses on hematological malignancies, neuro-degeneration, fibrosis and cardiovascular disease areas. Miragen lead pipeline products candidates are Cobomarsen (MRG-106), an inhibitor of microRNA-155 for treating blood cancers; Remlarsen (MRG-201), a replacement for miR-29 for treating or preventing pathologic fibrosis and MRG-110, an inhibitor of microRNA-92 for treating ischemic conditions. Miragen is headquartered in Boulder, Colorado, the US.
Scope
- Detailed information on Miragen Therapeutics Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Miragen Therapeutics Inc in the form of a SWOT analysis
- An in-depth view of the business model of Miragen Therapeutics Inc including a breakdown and examination of key business segments
- News about Miragen Therapeutics Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Miragen Therapeutics Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Miragen Therapeutics Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Miragen Therapeutics Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Regulus Therapeutics Inc
Novartis International AG
Mylan Pharmaceuticals Inc
Merck & Co Inc
Ionis Pharmaceuticals Inc
InteRNA Technologies BV
F. Hoffmann-La Roche Ltd
Dicerna Pharmaceuticals ...
Regulus Therapeutics Inc
Novartis International AG
Mylan Pharmaceuticals Inc
Merck & Co Inc
Ionis Pharmaceuticals Inc
InteRNA Technologies BV
F. Hoffmann-La Roche Ltd
Dicerna Pharmaceuticals Inc
Celgene Corp
Bristol-Myers Squibb Co
Arrowhead Pharmaceuticals Inc
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Miragen Therapeutics Inc - Key Facts
Miragen ...
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Miragen Therapeutics Inc - Key Facts
Miragen Therapeutics Inc - Key Employees
Miragen Therapeutics Inc - Key Employee Biographies
Miragen Therapeutics Inc - Major Products and Services
Miragen Therapeutics Inc - History
Miragen Therapeutics Inc - Company Statement
Miragen Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Miragen Therapeutics Inc - Business Description
R&D Overview
Miragen Therapeutics Inc - Corporate Strategy
Miragen Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Miragen Therapeutics Inc - Strengths
Miragen Therapeutics Inc - Weaknesses
Miragen Therapeutics Inc - Opportunities
Miragen Therapeutics Inc - Threats
Miragen Therapeutics Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Miragen Therapeutics Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Miragen Therapeutics Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Miragen Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 08, 2019: miRagen announces first quarter 2019 financial results and provides corporate update
Mar 13, 2019: miRagen announces fourth quarter and full year 2018 financial results and provides 2019 outlook
Dec 05, 2018: miRagen Therapeutics announces board of director evolution and appointment of new chairman
Nov 07, 2018: miRagen Therapeutics reports third quarter 2018 financial results and provides corporate update
Aug 07, 2018: miRagen Therapeutics announces second quarter 2018 financial results
May 09, 2018: miRagen Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
Mar 14, 2018: miRagen Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
Jan 05, 2018: miRagen Therapeutics Expands Board of Directors With Appointment of Arlene Morris
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
List of Tables
Miragen Therapeutics Inc, Key Facts
Miragen Therapeutics Inc, Key Employees
Miragen Therapeutics Inc, Key Employee Biographies
Miragen Therapeutics Inc, Major Products and ...
List of Tables
Miragen Therapeutics Inc, Key Facts
Miragen Therapeutics Inc, Key Employees
Miragen Therapeutics Inc, Key Employee Biographies
Miragen Therapeutics Inc, Major Products and Services
Miragen Therapeutics Inc, History
Miragen Therapeutics Inc, Subsidiaries
Miragen Therapeutics Inc, Key Competitors
Miragen Therapeutics Inc, Ratios based on current share price
Miragen Therapeutics Inc, Annual Ratios
Miragen Therapeutics Inc, Annual Ratios (Cont...1)
Miragen Therapeutics Inc, Interim Ratios
Miragen Therapeutics Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Miragen Therapeutics Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Miragen Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
List of Figures
Miragen Therapeutics Inc, Performance Chart (2014 - 2018)
Miragen Therapeutics Inc, Ratio Charts
Miragen Therapeutics Inc, Medical Equipment, Deals By Year, 2013 ...
List of Figures
Miragen Therapeutics Inc, Performance Chart (2014 - 2018)
Miragen Therapeutics Inc, Ratio Charts
Miragen Therapeutics Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Miragen Therapeutics Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019